Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Doran

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Biopharmaceutics & Drug Disposition|February 24, 2023
Investigating CNS distribution of PF-05212377, a P-glycoprotein substrate, by translation of 5-HT<sub>6</sub> receptor occupancy from non-human primates to humansAarti Sawant-Basak, Laigao Chen, Peter Lockwood, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Post-transcriptional modifications on tRNA fragments confer functional changes to high-density lipoproteins in atherosclerosisElizabeth M Semler, Danielle L Michell, Philip J Kingsley, et al.
Cardiovascular Research|June 14, 2023
Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failureCharles Duncan Smart, Daniel J Fehrenbach, Jean W Wassenaar, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2022
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Amanda King-Ahmad, et al.
ACS Chemical Neuroscience|June 14, 2017
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) InhibitorsTravis T Wager, Paul Galatsis, Ramalakshmi Y Chandrasekaran, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 24, 2024
The consumption of animal products is associated with plasma levels of alpha-aminoadipic acid (2-AAA)Olivia R Antonetti, Stacy Desine, Holly M Smith, et al.
ACS Chemical Biology|August 2, 2023
Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by MacrophagesJonah E Zarrow, Abdul-Musawwir Alli-Oluwafuyi, Cristina M Youwakim, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by MacrophagesJonah E Zarrow, Abdul-Musawwir Alli-Oluwafuyi, Cristina M Youwakim, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2005
Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue bindingXingrong Liu, Bill J Smith, Cuiping Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2006
Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentrationXingrong Liu, Bill J Smith, Cuiping Chen, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Biopharmaceutics & Drug Disposition|February 24, 2023
Investigating CNS distribution of PF-05212377, a P-glycoprotein substrate, by translation of 5-HT<sub>6</sub> receptor occupancy from non-human primates to humansAarti Sawant-Basak, Laigao Chen, Peter Lockwood, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Post-transcriptional modifications on tRNA fragments confer functional changes to high-density lipoproteins in atherosclerosisElizabeth M Semler, Danielle L Michell, Philip J Kingsley, et al.
Cardiovascular Research|June 14, 2023
Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failureCharles Duncan Smart, Daniel J Fehrenbach, Jean W Wassenaar, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2022
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Amanda King-Ahmad, et al.
ACS Chemical Neuroscience|June 14, 2017
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) InhibitorsTravis T Wager, Paul Galatsis, Ramalakshmi Y Chandrasekaran, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 24, 2024
The consumption of animal products is associated with plasma levels of alpha-aminoadipic acid (2-AAA)Olivia R Antonetti, Stacy Desine, Holly M Smith, et al.
ACS Chemical Biology|August 2, 2023
Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by MacrophagesJonah E Zarrow, Abdul-Musawwir Alli-Oluwafuyi, Cristina M Youwakim, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by MacrophagesJonah E Zarrow, Abdul-Musawwir Alli-Oluwafuyi, Cristina M Youwakim, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2005
Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue bindingXingrong Liu, Bill J Smith, Cuiping Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2006
Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentrationXingrong Liu, Bill J Smith, Cuiping Chen, et al.
Pageof 11